We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.4B
AUM Growth
+$1.27B
Cap. Flow
+$730M
Cap. Flow %
3.41%
Top 10 Hldgs %
26.79%
Holding
881
New
137
Increased
443
Reduced
202
Closed
30

Top Buys

Rank Stock Value
1
AU icon
AngloGold Ashanti
AU
+$259M
2
VALE icon
Vale
VALE
+$83M
3
WPX
WPX Energy, Inc.
WPX
+$44.4M
4
GFI icon
Gold Fields
GFI
+$39.7M
5
RGLD icon
Royal Gold
RGLD
+$35.7M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$109M
2
NEM icon
Newmont
NEM
+$96M
3
B
Barrick Mining
B
+$77.1M
4
FNV icon
Franco-Nevada
FNV
+$63.2M
5
GG
Goldcorp Inc
GG
+$58M

Sector Composition

Rank Sector Weight
1 Materials 50.75%
2 Energy 16.94%
3 Healthcare 6.45%
4 Technology 5.96%
5 Consumer Staples 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LE icon
751
Lands' End
LE
$361M
$69K ﹤0.01%
2,456
– –
UFS
752
DELISTED
DOMTAR CORPORATION (New)
UFS
$67K ﹤0.01%
1,403
-83
-6% -$3.85K
EDU icon
753
New Oriental
EDU
$7.84B
$66K ﹤0.01%
+700
New +$67K
MSGS icon
754
Madison Square Garden
MSGS
$9.54B
$66K ﹤0.01%
300
– –
WPG
755
DELISTED
Washington Prime Group Inc.
WPG
$66K ﹤0.01%
899
– –
LW icon
756
Lamb Weston
LW
$6.82B
$65K ﹤0.01%
956
– –
XHR
757
Xenia Hotels & Resorts
XHR
$1.98B
$65K ﹤0.01%
2,654
– –
AVNS icon
758
Avanos Medical
AVNS
$1.17B
$64K ﹤0.01%
1,110
– –
DNOW icon
759
DNOW Inc
DNOW
$2.63B
$64K ﹤0.01%
4,801
– –
UNIT
760
Uniti Group
UNIT
$2.63B
$64K ﹤0.01%
3,192
– –
CTRE icon
761
CareTrust REIT
CTRE
$10.2B
$63K ﹤0.01%
3,781
– –
ENR icon
762
Energizer
ENR
$1.44B
$63K ﹤0.01%
1,002
– –
PRAH
763
DELISTED
PRA Health Sciences, Inc.
PRAH
$63K ﹤0.01%
675
– –
KN icon
764
Knowles
KN
$3.22B
$62K ﹤0.01%
4,027
– –
MGIC
765
DELISTED
Magic Software Enterprises
MGIC
$61K ﹤0.01%
7,342
+884
+14% +$7.36K
PK icon
766
Park Hotels & Resorts
PK
$2.97B
$61K ﹤0.01%
1,979
– –
RDHL
767
Redhill Biopharma
RDHL
$3.85M
$61K ﹤0.01%
7
+3
+75% +$19.1K
CSW
768
CSW Industrials
CSW
$4.71B
$60K ﹤0.01%
1,139
– –
OGS icon
769
ONE Gas
OGS
$5.05B
$60K ﹤0.01%
799
– –
RDCM icon
770
Radcom
RDCM
$218M
$60K ﹤0.01%
3,029
+203
+7% +$3.95K
NRE
771
DELISTED
NorthStar Realty Europe Corp.
NRE
$60K ﹤0.01%
4,125
– –
KEYS icon
772
Keysight
KEYS
$54.5B
$59K ﹤0.01%
1,006
– –
WBT
773
DELISTED
Welbilt, Inc.
WBT
$59K ﹤0.01%
2,653
– –
QCP
774
DELISTED
Quality Care Properties, Inc.
QCP
$59K ﹤0.01%
2,724
– –
CVEO icon
775
Civeo
CVEO
$379M
$58K ﹤0.01%
1,107
– –
29 30
31
32 33

Similar funds

National Pension Service
National Pension Service Jeonju-Si, Jeollabuk-Do, South Korea $132B AUM 28.96% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VanEck Associates's Q2 2018 Portfolio in Review

As of Q2 2018, VanEck Associates held 881 positions worth $21.4B, up 6.3% from $20.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

VanEck Associates deployed $730M of net new capital in Q2 2018, opening 137 new positions and adding to 443 existing holdings. Its largest new stake was Colgate-Palmolive: 345,613 shares worth $22.4M.

By sector, the portfolio is most concentrated in Materials at 51% of assets, down from 52% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Newmont, an estimated $96M trimmed.

  • VanEck Associates's largest Q2 2018 buy was Colgate-Palmolive: 345,613 shares worth $22.4M.
  • VanEck Associates added most to AngloGold Ashanti in Q2 2018, an estimated $259M increase.
  • VanEck Associates's biggest Q2 2018 reduction was Newmont, cutting an estimated $96M.
  • VanEck Associates fully exited Monsanto Co in Q2 2018, selling an estimated $109M.
  • VanEck Associates's ten largest holdings make up 27% of its $21.4B portfolio in Q2 2018.
  • VanEck Associates opened 137 new positions and closed 30 in Q2 2018.
  • VanEck Associates's portfolio value rose 6.3% quarter-over-quarter to $21.4B.

Based on VanEck Associates's 13F filing for Q2 2018, filed 13 Aug 2018.